[Current state of vaccination against SARS-CoV-2].

[Current state of vaccination against SARS-CoV-2].
Z Rheumatol. 2021 Feb 02;:
Authors: Iking-Konert C, Specker C, Krüger K, Schulze-Koops H, Aries P
Abstract
On 21 December 2020 the European Medicines Agency (EMA) approved the mRNA vaccine BNT162b2 (Comirnaty®, BioNTech, Mainz, Germany; Pfizer, New York City, NY, USA) as the first vaccine against SARS-CoV‑2 in the European Union and the second vaccine (Moderna®, Moderna, Cambridge, MA, USA) followed on 6 January 2021. Many more approvals will follow within a short period of time. With the availability of the vaccination many questions have arisen for patients as well as for physicians, which are addressed as up to date as possible in this hot topic article.
PMID: 33528655 [PubMed - as supplied by publisher]

Source: Zeitschrift fur Rheumatologie - February 2, 2021 Category: Rheumatology Authors: Iking-Konert C, Specker C, Krüger K, Schulze-Koops H, Aries P Tags: Z Rheumatol Source Type: research